(Q40829966)

24 September 2017

1 reference

title

Quality of life measures in psoriasis: a critical appraisal of their quality (English)

1 reference

24 September 2017

1 reference

1

1 reference

24 September 2017

Li Wan Po A

2

1 reference

24 September 2017

Williams HC

series ordinal

3

1 reference

24 September 2017

Griffiths CE

series ordinal

4

1 reference

24 September 2017

1 October 1998

1 reference

Journal of Clinical Pharmacy and Therapeutics

24 September 2017

1 reference

24 September 2017

23

1 reference

24 September 2017

391-398

1 reference

24 September 2017

5

1 reference

The outcomes movement and new measures of the severity of psoriasis

24 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

A survey of the social and psychological effects of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Psoriasis: an audit of patients' views on the disease and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Trivial or terrible? The psychosocial impact of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Feelings of stigmatization in patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Quality of life measures in health care. II: Design, analysis, and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Quality of life measurement in dermatology: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Postal questionnaire study of disability in the community associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

The Psoriasis Disability Index--further analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Dermatology in-patient management greatly improves life quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

What are quality of life measurements measuring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Assessing the preferences of patients with psoriasis. A quantitative, utility approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Utility approach to measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

Economic evaluation of new drug therapies in terms of improved life quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00181.X

10.1046/J.1365-2710.1998.00181.X

21 January 2018

Identifiers

DOI

1 reference

release_7v3taulljbfj5mckf6jvvwu2oq

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7v3taulljbfj5mckf6jvvwu2oq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference